Literature DB >> 10997999

Thalidomide therapy in refractory solid tumour patients.

J Gutheil, D Finucane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997999     DOI: 10.1046/j.1365-2141.2000.02239-11.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Antitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice.

Authors:  Jean Marie B. Ruddy; Shyamal K. Majumdar
Journal:  J Biomed Biotechnol       Date:  2002

2.  Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells.

Authors:  J B Marriott; I A Clarke; K Dredge; G Muller; D Stirling; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

3.  Thalidomide-induced severe neutropenia during treatment of multiple myeloma.

Authors:  Yutaka Hattori; Tsunayuki Kakimoto; Shinichiro Okamoto; Norihide Sato; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2004-04       Impact factor: 2.490

Review 4.  Ectopic localization of mitochondrial ATP synthase: a target for anti-angiogenesis intervention?

Authors:  Daniel J Kenan; Miriam L Wahl
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

5.  Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.

Authors:  J B Bartlett; A Michael; I A Clarke; K Dredge; S Nicholson; H Kristeleit; A Polychronis; H Pandha; G W Muller; D I Stirling; J Zeldis; A G Dalgleish
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

6.  Thalidomide for the treatment of refractory multiple myeloma: association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcome.

Authors:  Tsunayuki Kakimoto; Yutaka Hattori; Shinichiro Okamoto; Norihide Sato; Tamihiro Kamata; Masaya Yamaguchi; Kunihiko Morita; Taketo Yamada; Nobuyuki Takayama; Hideo Uchida; Naoki Shimada; Yusuke Tanigawara; Yasuo Ikeda
Journal:  Jpn J Cancer Res       Date:  2002-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.